Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients

Documenti analoghi

• Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model
  di: Raven, Peter A, et al.
  Pubblicazione: (2018)
• Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma
  di: D’Costa, Ninadh M., et al.
  Pubblicazione: (2020)
• Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients
  di: Zhou, Chaoting, et al.
  Pubblicazione: (2021)
• The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
  di: Frees, Sebastian, et al.
  Pubblicazione: (2018)
• Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer
  di: Peng, Fei, et al.
  Pubblicazione: (2017)